#CancerMoonshot today will not only be about glioblastoma, but about the horrible DIPG (diffuse intrinsic pontine glioma) occuring in children and young adults.
You know who got their PIP plan approved last year by the MHRA in the UK?
You know who ANNOUNCED a new center of cancer excellence in Sutton in the UK two months ago, 130 miles from Sawston, focusing on DIPG?
You know who donated 2.5 million pounds to the center and that Hugh Adams works for them and have helped NWBO meeting british politicians and he wrote the "Pathway to a Cure" report, where politicians urges MHRA and NICE to get DCVax-L to patients?
SAME DAY MHRA announced this
"This new funding will accelerate the delivery of cutting-edge treatments like cancer vaccines"
One week later the MHRA announced this.
The new Quarterly SEC filing says
"We plan to work on preparations for Phase II trials of DCVax-Direct as resources permit."
You know NWBO already had planned DCVax-Direct trials in 2019 targeting DIPG?
Being a shareholder and being enlightened with the decade long harassment of NWBO by spoofing by several market makers - YES Cohen and Millstein HAVE taken the case on contingency as the proof of spoofing is overwhelming with +5 years of detailed trading transactions ....
- and 40 hit pieces to support this by Adam Feuerstein, correlating with an army of support on stock boards by shorters, fudders and paid bashing pawns making NWBO the most debated stock for over a year on Ihub, I would say the "burning of shareholders" is a discipline incited ..
... not by NWBO, but by this opposition, we could rationally call a crime syndicate.
NWBO not only survived though, by consistently being able to raise money, but they did it against all odds, which I bet, these Market Makers now are quite pissed about.
Let's look at news in the UK, that explicitly have pointed out the parent/child relationship of NWBO and the CDMO Advent Bioservices, situated on the same compound within the same building at Sawston, Cambridge, UK.
"Linda Powers, CEO of Northwest Biotherapeutics (NW Bio), has paid tribute to the clinical development team at Sawston Business Park – and contractor Advent BioServices"
2)
"The Maryland-based biotechnology company has been developing personalised immunotherapy products designed to treat solid tumour cancers, with input from its R&D team at Sawston"
At the NYAS presentation May 5th., @StevenBremMD from UPenn was given the word by the Session Host George Zavoio, now employed by NWBO.
Dr. Stephen Brem:
"Yeah, I wanted to answer David’s question… and congratulate Paul Mulholland -->
".. the Northwest Bio team. Without being self-congratulatory… full disclosure… I’m one of the seventy authors, and we’ve been waiting for an advance like this for a long time.
"David, in addition to the external controls and the numbers, we have some unpublished data from ->
... Penn. and Dr. Mulholland’s team has been looking at radiological markers, and we’ll present that in June. That will obviously add to the story in terms of using each patient as a control, and having another dimension of efficacy. Thank you."
"We have included 5 new sites in this year’s manufacturing survey, one of which (Advent) acquired their MIA (IMP) just shortly after the publication of last year’s manufacturing report, and anticipates
gaining their MIA shortly"
"The overall picture of the dedicated GMP cell therapy
manufacturing sector is one moving in a positive direction, while the number of facilities remains static at 10, there has been a notable expansion of capacity, primarily driven by the addition of the large Advent site."
Advent Bioservices are planning additional cleanrooms (Q2 2023) and a large expansion of its PD space (Q4 2022). They are also planning to obtain an MIA for commercial manufacturing
NWBO's been constantly the most debated stock on Investorshub.
I'm a very outspoken guy. A biotech having worked upon a cancer vaccine in 20 years, being traded at $0,68 a share, does not become most discussed stock, due to having failed.
But because it succeeded.
Let's state it clear.
8 hedges having spoofed and naked shorting NWBO for +5 years, correlated with Adam Feuerstein having written manipulative lying articles for The Street and STATNEWS for 10 years and dozens of pawns on stockboards doing the dirty bidding of paid bashing ...
No ... that did NOT bring NWBO down.
They did not go bankrupt.
They reached data lock.
They got published in one of the most prestigious medicine magazines.
They managed to build a new CDMO around their cancer vaccine.